Related references
Note: Only part of the references are listed.Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF- and miR23a transfer
Guy Berchem et al.
ONCOIMMUNOLOGY (2016)
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
Julia M. Greene et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Combining Epigenetic and Immunotherapy to Combat Cancer
Katherine B. Chiappinelli et al.
CANCER RESEARCH (2016)
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Christine Pasero et al.
CANCER RESEARCH (2016)
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Hong Zheng et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
Andrea Schietinger et al.
IMMUNITY (2016)
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors
Ellen M. Doorduijn et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion
Eunseon Ahn et al.
JOURNAL OF VIROLOGY (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
Michiel van der Vlist et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
MicroRNA-491 regulates the proliferation and apoptosis of CD8+ T cells
Ting Yu et al.
SCIENTIFIC REPORTS (2016)
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis
Rink-Jan Lohman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
RORC1 Regulates Tumor-Promoting Emergency Granulo-Monocytopoiesis
Laura Strauss et al.
CANCER CELL (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210
Muhammad Zaeem Noman et al.
CANCER RESEARCH (2015)
Immunotherapy: The Path to Win the War on Cancer?
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
The Chromatin-Modifying Enzyme Ezh2 Is Critical for the Maintenance of Regulatory T Cell Identity after Activation
Michel DuPage et al.
IMMUNITY (2015)
MicroRNA regulation of lymphocyte tolerance and autoimmunity
Laura J. Simpson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1
Jie Tian et al.
JOURNAL OF IMMUNOLOGY (2015)
Mesenchymal Stem/Stromal Cells Protect against Autoimmunity via CCL2-Dependent Recruitment of Myeloid-Derived Suppressor Cells
Hyun Ju Lee et al.
JOURNAL OF IMMUNOLOGY (2015)
Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8
Jessica Margaret Sido et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer
Anna Maria Rusek et al.
MOLECULAR CANCER (2015)
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function
Eva Sahakian et al.
MOLECULAR IMMUNOLOGY (2015)
Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection
D. E. de Almeida Nagata et al.
MUCOSAL IMMUNOLOGY (2015)
Function and information content of DNA methylation
Dirk Schuebeler
NATURE (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
Jie Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells
Seunghee Lee et al.
SCIENTIFIC REPORTS (2015)
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
David M. Woods et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Critical role of tumor microenvironment in shaping NK cell functions: implication of hypoxic stress
Meriem Hasmim et al.
FRONTIERS IN IMMUNOLOGY (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
MicroRNA-146a and MicroRNA-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins
Haein Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4+ Regulatory T Cells in Tumors from Mice and Humans
Jeremy D. Waight et al.
JOURNAL OF IMMUNOLOGY (2015)
MAGED4 Expression in Glioma and Upregulation in Glioma Cell Lines with 5-Aza-2'-Deoxycytidine Treatment
Qing-Mei Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1
Haejung Won et al.
BLOOD (2014)
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
David D. W. Twa et al.
BLOOD (2014)
Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma
Jacek Jan Sznurkowski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth
Yuan Yin et al.
CELL RESEARCH (2014)
Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
Jessica M. Haverkamp et al.
IMMUNITY (2014)
MicroRNA 21 (miR-21) and miR-181b Couple with NFI-A To Generate Myeloid-Derived Suppressor Cells and Promote Immunosuppression in Late Sepsis
Clara McClure et al.
INFECTION AND IMMUNITY (2014)
MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5
Wei Li et al.
INTERNATIONAL IMMUNOLOGY (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Targeting miR-23a in CD8(+) cytotoxic T lymphocytes prevents tumor-dependent immunosuppression
Regina Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
Limin Li et al.
JOURNAL OF IMMUNOLOGY (2014)
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
Daniel W. Beury et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
H. Yang et al.
LEUKEMIA (2014)
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
G. Comito et al.
ONCOGENE (2014)
MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene
J. Yang et al.
ONCOGENE (2014)
Epigenetic drugs as immunomodulators for combination therapies in solid tumors
Luca Sigalotti et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
KiBem Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells
Sarah S. Donatelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells
Xue Zhang et al.
EPIGENETICS & CHROMATIN (2014)
Epigenetic plasticity of Cd8a locus during CD8+ T-cell development and effector differentiation and reprogramming
Kim L. Harland et al.
NATURE COMMUNICATIONS (2014)
Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes
Veronika Vlkova et al.
ONCOTARGET (2014)
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Huili Li et al.
ONCOTARGET (2014)
HDAC inhibitors and immunotherapy; a double edged sword?
Michiel Kroesen et al.
ONCOTARGET (2014)
Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
Malgorzata Wachowska et al.
ONCOIMMUNOLOGY (2014)
TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes
Faten El Hage et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
Immune-suppressive properties of the tumor microenvironment
Juergen C. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
Tsuyoshi Osawa et al.
CANCER RESEARCH (2013)
Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
Thomas A. Mace et al.
CANCER RESEARCH (2013)
Trichostatin A Promotes the Generation and Suppressive Functions of Regulatory T Cells
Cristian Donas et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Development and Maintenance of Regulatory T cells
Naganari Ohkura et al.
IMMUNITY (2013)
Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma
Kelly A. Cycon et al.
IMMUNOLOGY (2013)
KLF4 Modulates Expression of IL-6 in Dendritic Cells via Both Promoter Activation and Epigenetic Modification
Jason M. Rosenzweig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Distinct MicroRNA Expression Profile and Targeted Biological Pathways in Functional Myeloid-derived Suppressor Cells Induced by Δ9-Tetrahydrocannabinol in Vivo
Venkatesh L. Hegde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway
Andong Qin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Exosomes in tumor microenvironment influence cancer progression and metastasis
Christoph Kahlert et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn et al.
NATURE IMMUNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M. Woods et al.
MELANOMA RESEARCH (2013)
Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility
O. Aprelikova et al.
ONCOGENE (2013)
Epigenetic regulation of macrophage polarization and function
Lionel B. Ivashkiv
TRENDS IN IMMUNOLOGY (2013)
Alterations of immune response of non-small cell lung cancer with Azacytidine
John Wrangle et al.
ONCOTARGET (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Winston Timp et al.
NATURE REVIEWS CANCER (2013)
Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression
Ermira Pazolli et al.
CANCER RESEARCH (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
MicroRNAs in Vascular and Metabolic Disease
Anna Zampetaki et al.
CIRCULATION RESEARCH (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocyte-derived dendritic cells in different environments
Y. Huang et al.
GENES AND IMMUNITY (2012)
T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development
Naganari Ohkura et al.
IMMUNITY (2012)
MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
Yang Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression
Lucas E. Rossi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Editorial: HDAC inhibition begets more MDSCs
Pavan Reddy
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo
Brian R. Rosborough et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells
Jay H. Kalin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activation
Jian Du et al.
MEDICAL ONCOLOGY (2012)
Breast Cancer Cells Induce Stromal Fibroblasts to Secrete ADAMTS1 for Cancer Invasion through an Epigenetic Change
Shiaw-Wei Tyan et al.
PLOS ONE (2012)
Tumor associated regulatory dendritic cells
Yang Ma et al.
SEMINARS IN CANCER BIOLOGY (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
MicroRNA-181a Regulates Local Immune Balance by Inhibiting Proliferation and Immunosuppressive Properties of Mesenchymal Stem Cells
Liu Liu et al.
STEM CELLS (2012)
miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages
Mario Leonardo Squadrito et al.
CELL REPORTS (2012)
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects
Alison C. West et al.
ONCOIMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
Thierry Roger et al.
BLOOD (2011)
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
J. Simova et al.
BRITISH JOURNAL OF CANCER (2011)
The Present and Future of Peptide Vaccines for Cancer Single or Multiple, Long or Short, Alone or in Combination?
Craig L. Slingluff
CANCER JOURNAL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer
Nicolo Rigamonti et al.
CLINICAL CANCER RESEARCH (2011)
Impact of the hypomethylating agent 5-azacytidine on dendritic cells function
Jihane Frikeche et al.
EXPERIMENTAL HEMATOLOGY (2011)
miR-223 suppresses differentiation of tumor-induced CD11b+Gr1+myeloid-derived suppressor cells from bone marrow cells
Qiaofei Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression
Miaomiao Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
HDAC Inhibition and Graft Versus Host Disease
Sung Choi et al.
MOLECULAR MEDICINE (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Christian Steidl et al.
NATURE (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer
M. Musumeci et al.
ONCOGENE (2011)
Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells
Alice E. Denton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice
Kenta Misaki et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression
Alfonso Serrano et al.
Cancers (2011)
Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells
Holger Weishaupt et al.
BLOOD (2010)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Scott A. Bergfeld et al.
CANCER AND METASTASIS REVIEWS (2010)
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine
Irina Daurkin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Barbara Seliger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
Olga Aprelikova et al.
CELL CYCLE (2010)
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+Tregs
Tatiana Akimova et al.
CLINICAL IMMUNOLOGY (2010)
Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
Edwin F. de Zoeten et al.
GASTROENTEROLOGY (2010)
The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
Maika Almstedt et al.
LEUKEMIA RESEARCH (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Physiological and pathological roles for microRNAs in the immune system
Ryan M. O'Connell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Epigenetic regulation of the alternatively activated macrophage phenotype
Makoto Ishii et al.
BLOOD (2009)
MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβ
Min He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Quantitative expression and immunogenicity of MAGE-3 and-6 in upper aerodigestive tract cancer
Pedro A. Andrade Filho et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: Negative Regulation of Dendritic Cells through Acetylation of the Nonhistone Protein STAT-3
Yaping Sun et al.
JOURNAL OF IMMUNOLOGY (2009)
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra et al.
NATURE IMMUNOLOGY (2009)
Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3
Yung-Chi Chang et al.
BLOOD (2008)
Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts
Le Jiang et al.
CANCER RESEARCH (2008)
Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
A. Francesca Setiadi et al.
CANCER RESEARCH (2008)
The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma
Atsushi Natsume et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma
Takashi Murakami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
R. Schickel et al.
ONCOGENE (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hemopoietic progenitor to NK cells
Simeon Santourlidis et al.
JOURNAL OF IMMUNOLOGY (2008)
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment
Konrad A. Bode et al.
IMMUNOLOGY (2007)
Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor
Jason A. Dubovsky et al.
PROSTATE (2007)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Epigenetic control of the immune escape mechanisms in malignant carcinomas
A. Francesca Setiadi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Alessio Nencioni et al.
CLINICAL CANCER RESEARCH (2007)
Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-γ during the differentiation of T helper type 2 cells
Shaojing Chang et al.
NATURE IMMUNOLOGY (2007)
Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment
Carl R. Walkley et al.
CELL (2007)
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2′-deoxycytidine in cutaneous melanoma:: Immunotherapeutic implications
Ester Fonsatti et al.
CLINICAL CANCER RESEARCH (2007)
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Cunren Liu et al.
BLOOD (2007)
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Jennifer L. Brogdon et al.
BLOOD (2007)
Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection
Angelina Jane Mosley et al.
BLOOD (2006)
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
Guillermo Garcia-Manero et al.
BLOOD (2006)
Epigenetic regulation of tumor endothelial cell anergy:: Silencing of intercellular adhesion molecule-1 by histone modifications
Debby M. E. I. Hellebrekers et al.
CANCER RESEARCH (2006)
Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b
S. R. James et al.
ONCOGENE (2006)
Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: Critical roles of IFN-inducible protein-10
F Nishimura et al.
CANCER RESEARCH (2006)
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Rainer Glauben et al.
JOURNAL OF IMMUNOLOGY (2006)
De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
ZS Guo et al.
CANCER RESEARCH (2006)
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Breast cancer DNA methylation profiles in cancer cells and tumor stroma: Association with HER-2/neu status in primary breast cancer
H Fiegl et al.
CANCER RESEARCH (2006)
Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer
Sergei Kusmartsev et al.
CANCER AND METASTASIS REVIEWS (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B
S Skov et al.
CANCER RESEARCH (2005)
Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells
SD Chou et al.
INTERNATIONAL IMMUNOLOGY (2005)
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D Ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu et al.
CANCER RESEARCH (2005)
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
WK Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells
S Santourlidis et al.
JOURNAL OF IMMUNOLOGY (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy
JK Christman
ONCOGENE (2002)
Histone methylation in transcriptional control
T Kouzarides
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Histone acetylation: a switch between repressive and permissive chromatin - Second in review series on chromatin dynamics
A Eberharter et al.
EMBO REPORTS (2002)
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival
PP Lee et al.
IMMUNITY (2001)
Expression of HLA class I antigens and restoration of antigen-specific ctl response in melanoma cells following 5-aza-2′-deoxycytidine treatment
A Serrano et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
WJ Magner et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
